ATE412631T1 - Indolderivate als progesteron-rezeptormodulatoren - Google Patents

Indolderivate als progesteron-rezeptormodulatoren

Info

Publication number: ATE412631T1
Authority: AT; Austria
Prior art keywords: progesterone receptor; indole derivatives; prevention; treatment; receptor modulators
Prior art date: 2004-10-27

Application number

AT05816083T

Other languages

English (en)

Inventor

Weiqin Johnson Jiang

James Fiordeliso

Zhihua Johnson Sui

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-10-27

Filing date

2005-10-21

Publication date

2008-11-15

2005-10-21 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2008-11-15 Application granted granted Critical

2008-11-15 Publication of ATE412631T1 publication Critical patent/ATE412631T1/de

Links

229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical class C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
239000002379 progesterone receptor modulator Substances 0.000 title 1
229940095745 sex hormone and modulator of the genital system progesterone receptor modulator Drugs 0.000 title 1
230000000740 bleeding effect Effects 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
230000002265 prevention Effects 0.000 abstract 2
201000000736 Amenorrhea Diseases 0.000 abstract 1
206010001928 Amenorrhoea Diseases 0.000 abstract 1
201000009030 Carcinoma Diseases 0.000 abstract 1
201000009273 Endometriosis Diseases 0.000 abstract 1
208000009956 adenocarcinoma Diseases 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
231100000540 amenorrhea Toxicity 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
210000000481 breast Anatomy 0.000 abstract 1
210000001072 colon Anatomy 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
210000004696 endometrium Anatomy 0.000 abstract 1
230000037406 food intake Effects 0.000 abstract 1
235000012631 food intake Nutrition 0.000 abstract 1
150000002475 indoles Chemical class 0.000 abstract 1
230000001404 mediated effect Effects 0.000 abstract 1
230000002175 menstrual effect Effects 0.000 abstract 1
210000001672 ovary Anatomy 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
201000010065 polycystic ovary syndrome Diseases 0.000 abstract 1
102000003998 progesterone receptors Human genes 0.000 abstract 1
108090000468 progesterone receptors Proteins 0.000 abstract 1
210000002307 prostate Anatomy 0.000 abstract 1
230000000638 stimulation Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Endocrinology (AREA)
Diabetes (AREA)
Reproductive Health (AREA)
Nutrition Science (AREA)
Gynecology & Obstetrics (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Indole Compounds (AREA)

AT05816083T 2004-10-27 2005-10-21 Indolderivate als progesteron-rezeptormodulatoren ATE412631T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US62258204P	2004-10-27	2004-10-27

Publications (1)

Publication Number	Publication Date
ATE412631T1 true ATE412631T1 (de)	2008-11-15

Family

ID=35735187

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT05816083T ATE412631T1 (de)	2004-10-27	2005-10-21	Indolderivate als progesteron-rezeptormodulatoren

Country Status (15)

Country	Link
US (2)	US7183309B2 (de)
EP (1)	EP1809602B1 (de)
JP (1)	JP5190268B2 (de)
CN (1)	CN101087758B (de)
AT (1)	ATE412631T1 (de)
AU (1)	AU2005302706B2 (de)
CA (1)	CA2585334C (de)
CY (1)	CY1109919T1 (de)
DE (1)	DE602005010734D1 (de)
DK (1)	DK1809602T3 (de)
ES (1)	ES2314739T3 (de)
PL (1)	PL1809602T3 (de)
PT (1)	PT1809602E (de)
SI (1)	SI1809602T1 (de)
WO (1)	WO2006049889A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN101374808B (zh)	2006-01-24	2011-05-25	伊莱利利公司	孕酮受体的吲哚磺酰胺调节剂
HRP20160689T1 (hr) *	2007-04-20	2016-07-15	Preglem S.A.	Selektivni modulatori progesterona za tretman uterinog krvarenja
CN111153849B (zh) *	2019-12-19	2021-03-26	南京林业大学	一种2-吲哚甲醇在水相反应体系中合成c3位硫醚化吲哚衍生物的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5081138A (en) *	1986-12-17	1992-01-14	Merck Frosst Canada, Inc.	3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
UA68365C2 (en) *	1997-11-06	2004-08-16	Wyeth Corp	Peroral contraception by combination of anti-estrogen and progestin
CA2322163A1 (en)	1998-02-25	1999-09-02	John Mckew	Inhibitors of phospholipase a2
US6355648B1 (en)	1999-05-04	2002-03-12	American Home Products Corporation	Thio-oxindole derivatives
EP1390029B1 (de) *	2001-04-11	2009-12-16	Idenix (Cayman) Limited	Phenylindole zur behandlung von hiv
SE0201635D0 (sv) *	2002-05-30	2002-05-30	Astrazeneca Ab	Novel compounds
SE0202241D0 (sv) *	2002-07-17	2002-07-17	Astrazeneca Ab	Novel Compounds

2005
- 2005-10-21 PT PT05816083T patent/PT1809602E/pt unknown
- 2005-10-21 PL PL05816083T patent/PL1809602T3/pl unknown
- 2005-10-21 DE DE602005010734T patent/DE602005010734D1/de not_active Expired - Lifetime
- 2005-10-21 JP JP2007538996A patent/JP5190268B2/ja not_active Expired - Fee Related
- 2005-10-21 AU AU2005302706A patent/AU2005302706B2/en not_active Ceased
- 2005-10-21 CN CN2005800446115A patent/CN101087758B/zh not_active Expired - Fee Related
- 2005-10-21 EP EP05816083A patent/EP1809602B1/de not_active Expired - Lifetime
- 2005-10-21 ES ES05816083T patent/ES2314739T3/es not_active Expired - Lifetime
- 2005-10-21 US US11/255,444 patent/US7183309B2/en not_active Expired - Fee Related
- 2005-10-21 DK DK05816083T patent/DK1809602T3/da active
- 2005-10-21 CA CA2585334A patent/CA2585334C/en not_active Expired - Fee Related
- 2005-10-21 SI SI200530551T patent/SI1809602T1/sl unknown
- 2005-10-21 AT AT05816083T patent/ATE412631T1/de active
- 2005-10-21 WO PCT/US2005/037817 patent/WO2006049889A1/en not_active Ceased
2007
- 2007-01-16 US US11/623,376 patent/US7345084B2/en not_active Expired - Fee Related
2009
- 2009-01-27 CY CY20091100097T patent/CY1109919T1/el unknown

Also Published As

Publication number	Publication date
US7345084B2 (en)	2008-03-18
JP5190268B2 (ja)	2013-04-24
DK1809602T3 (da)	2009-02-16
US7183309B2 (en)	2007-02-27
JP2008518009A (ja)	2008-05-29
ES2314739T3 (es)	2009-03-16
CN101087758A (zh)	2007-12-12
US20060111427A1 (en)	2006-05-25
SI1809602T1 (sl)	2009-04-30
CA2585334A1 (en)	2006-05-11
PT1809602E (pt)	2008-12-15
US20070135511A1 (en)	2007-06-14
AU2005302706A1 (en)	2006-05-11
CY1109919T1 (el)	2014-09-10
AU2005302706B2 (en)	2011-12-15
CA2585334C (en)	2014-05-13
EP1809602A1 (de)	2007-07-25
EP1809602B1 (de)	2008-10-29
PL1809602T3 (pl)	2009-04-30
WO2006049889A1 (en)	2006-05-11
CN101087758B (zh)	2012-06-06
DE602005010734D1 (de)	2008-12-11

Legal Events

Date

Code

Title

Description

2009-06-15

UEP

Publication of translation of european patent specification

Ref document number: 1809602

Country of ref document: EP

Publication	Publication Date	Title
CY1121926T1 (el)	2020-10-14	(11.βητα., 17.βητα.)-17-υδροξυ-11-[4(μεθυλοσουλφονυλο)φαινυλο]-17-(πενταφθορομεθυλο)οιστρα-4,9-διεν-3-ονη για την αγωγη παθησεων
EA201200860A1 (ru)	2013-01-30	Нейтрализующие пролактиновый рецептор антитела и их терапевтическое применение
ATE514700T1 (de)	2011-07-15	Neues tetrazyklisches heteroatom mit als sexualsteroidhormon-rezeptormodulatoren geeigneten derivaten
DE60035496D1 (de)	2007-08-23	Indolinderivate als progesteron antagonisten
CY1110017T1 (el)	2015-01-14	Μικρονισμενη ταναπρογετη και συνθεσεις που περιεχουν αυτην
BR0316843A (pt)	2005-11-01	Derivados tetracìclicos contendo heteroátomo como moduladores seletivos do receptor de estrogênio
WO2011098437A3 (de)	2011-10-27	Progesteronrezeptorantagonisten
DE602005019905D1 (de)	2010-04-22	-modulatoren
EP1896034B8 (de)	2010-05-19	Mikronisierte tanaproget zusammensetzungen und verfahren zu ihrer herstellung
TR200103285T2 (tr)	2002-02-21	Projesteron reseptörü modülatörleri olarak siklokarbamat türevleri.
CY1109919T1 (el)	2014-09-10	Παραγωγα της ινδολης που ειναι χρησιμα σα ρυθμιστες του υποδοχεα της προγεστερονης
ATE434434T1 (de)	2009-07-15	Zusammensetzungen mit mikronisiertem tanaproget
PT1173210E (pt)	2005-01-31	Composicoes contraceptivas antiprogestativos e progestativos
CY1121190T1 (el)	2020-05-29	Δοσολογικη μορφη ανταγωνιστη υποδοχεα προγεστερονης
MA32477B1 (fr)	2011-07-03	Derives estratrienes comprenant des bioisosteres heterocycliques pour le cycle a phenolique
EA200702604A1 (ru)	2008-06-30	Производные бензофуранона как нестероидные модуляторы рецептора прогестерона
EA200702524A1 (ru)	2008-06-30	Нестероидные модуляторы рецептора прогестерона
MX2009009515A (es)	2009-09-16	Cianopirrol sulfonamidas utiles para la modulacion del receptor de progesterona.
AR023854A1 (es)	2002-09-04	Uso de derivados de indolina y equipo farmaceutico para regimenes ciclicos
WO2008112498A3 (en)	2008-11-06	Synthesis and characterization of polymorph form ii of 4-(2-(4,4-dimethyl-2-oxooxazolidin-3-yl)thiazol-4-yl)benzonitrile